Literature DB >> 22109753

Significance and degree of reflux in patients with primary extraesophageal symptoms.

Kenneth C Fletcher1, Marion Goutte, James C Slaughter, C Gaelyn Garrett, Michael F Vaezi.   

Abstract

OBJECTIVES/HYPOTHESIS: Patients with extraesophageal symptoms are often suspected of having gastroesophageal reflux disease (GERD). However, the true prevalence and severity of reflux disease is not well studied. In this group of patients, the objectives of our study were to determine the prevalence and severity of esophageal acid exposure and classify the endoscopic findings. STUDY
DESIGN: Prospective cohort study.
METHODS: One hundred twenty-eight patients with extraesophageal symptoms underwent 48 hours of Bravo pH monitoring. Percent of time that pH was <4 (total upright and supine) was measured. Severity of reflux was categorized by the percent of total time pH was <4, with mild = >4.2% but <10%, moderate = 10% to 20%, and severe>20%. Endoscopic signs of esophagitis and Barrett's esophagus were determined.
RESULTS: There were 104/128 (81%) patients who had abnormal esophageal acid exposure, 44% in the upright and supine position, 38% in the upright position only, and 18% in the supine position only. There were 59/128 (46%) patients with mild reflux, 40/128 (31%) with moderate, and only 5/128 (4%) patients with severe reflux. 23/128 (18%) patients had evidence of esophagitis. Only 1/128 (0.8%) patients had pathologic Barrett's esophagus. Prevalence of abnormal esophageal acid exposure was similar in those with (75%) or without (66%) concomitant heartburn and/or regurgitation (P = .3).
CONCLUSIONS: Abnormal esophageal pH is common in patients with extraesophageal symptoms. Most have only mild (46%) to moderate (31%) reflux with a low prevalence of esophagitis (18%) or Barrett's esophagus (0.8%). The degree of esophageal acid reflux cannot be predicted from baseline presence or absence of typical GERD symptoms.
Copyright © 2011 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22109753     DOI: 10.1002/lary.22384

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

Review 1.  Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment.

Authors:  Christopher Hom; Michael F Vaezi
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

Review 2.  ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

Authors:  Philip O Katz; Kerry B Dunbar; Felice H Schnoll-Sussman; Katarina B Greer; Rena Yadlapati; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2022-01-01       Impact factor: 10.864

3.  New developments in extraesophageal reflux disease.

Authors:  Elif Saritas Yuksel; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-09

4.  The suitability of the GERDyzer instrument in pH-test-proven laryngopharyngeal reflux patients.

Authors:  Cheng-Pin Wu; Wen-Miin Liang; Chen-Chi Wang; Chi-Sen Chang; Hong-Zen Yeh; Jeng-Yuan Hsu; Chung-Wang Ko; Shou-Wu Lee; Shu-Chuan Chang; Fung-Chang Sung; Han-Chung Lien
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

5.  Atypical symptoms are related to typical symptoms rather than histologic and endoscopic esophagitis.

Authors:  Jung Hwan Oh
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.